Proteins related to the VEGF family are key regulators of normal as well as tumor angiogenesis and may serve as promising targets for anticancer therapies.[8] In recent years, antiangiogenic therapy has become increasingly popular in cancer treatment and has demonstrated potential benefits. The gene discussed is VEGFA; the disease is neoplasm.